Immunoprotective Effect of Probiotic Dahi Containing Lactobacillus acidophilus and Bifidobacterium bifidum on Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice

Probiotics and Antimicrobial Proteins

Volumn 4, Issue 1, 2012, Pages 21-26

  Jadhav, Sagar R ^a   Shandilya, Umesh Kr ^a   Kansal, Vinod K ^a  

^a NATIONAL DAIRY RESEARCH INSTITUTE   (India)

Author keywords

B. bifidum; Dextran sodium sulfate; L. acidophilus; LaBb Dahi; Myeloperoxidase; Ulcerative colitis

Indexed keywords

DAHI; DEXTRAN SULFATE; GAMMA INTERFERON; INTERLEUKIN 6; MYELOPEROXIDASE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIFIDOBACTERIUM BIFIDUM; BUFFALO; COCULTURE; CONTROLLED STUDY; DISEASE MARKER; ENZYME ACTIVITY; FEEDING; HISTOPATHOLOGY; IMMUNITY; LACTOBACILLUS ACIDOPHILUS; LACTOCOCCUS LACTIS; LACTOCOCCUS LACTIS CREMORIS; MALE; MILK; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THERAPY EFFECT; TREATMENT DURATION; ULCERATIVE COLITIS;

BIFIDOBACTERIUM BIFIDUM; LACTOBACILLUS ACIDOPHILUS; LACTOCOCCUS LACTIS; MUS;

EID: 84856734859     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-011-9087-2     Document Type: Article

References (39)

1. Langholz E, Munkholm P, Davidsen M, Binder V (1992) Colorectal cancer risk and mortality in patients with ulcerative colitis. Gastroenterology 103: 1444-1451.
2. Gillen CD, Walmsley RS, Prior P, Andrews HA, Allan RN (1994) Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. Gut 35: 1590-1592.
3. Regueiro M, Curtis J, Plevy S (2006) Infliximab for hospitalized patients with severe ulcerative colitis. J Clin Gastroenterol 40: 476-481.
4. Jakobovits SL, Jewell DP, Travis SP (2007) Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Aliment Pharmacol Ther 25: 1055-1060.
5. Lewis JD, Gelfand JM, Troxel AB, Forde KA, Newcomb C, Kim H, Margolis DJ, Strom BL (2008) Immunosuppressant medications and mortality in inflammatory bowel disease. Am J Gastroenterol 103: 1428-1435.
6. Report of a Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food Including Powder Milk with Live Lactic Acid Bacteria (2001) Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Food and Agriculture Organization of the United Nations, World Health Organization. Retrieved 2009-11-04.
7. Sartor RB (2008) Microbial influences in inflammatory bowel diseases. Gastroenterology 134: 577-594.
8. Rioux KP, Fedorak RN (2006) Probiotics in the treatment of inflammatory bowel disease. J Clin Gastroenterol 40: 260-263.
9. Fedorak RN, Madsen KL (2004) Probiotics and the management of inflammatory bowel disease. Inflamm Bowel Dis 10: 286-299.
10. Bibiloni R, Fedorak RN, Tannock GW, Madsen KL, Gionchetti P, Campieri M, De Simone C, Sartor RB (2005) VSL#3 probiotic-mixture induces remission in patients with active ulcerative colitis. Am J Gastroenterol 100: 1539-1546.
11. Kokesova A, Frolova L, Kverka M, Sokol D, Rossmann P, Bartova J, Tlaskalova-Hogenova H (2006) Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice. Folia Microbiol (Praha) 51: 478-484.
12. Rajpal S, Kansal VK (2008) Buffalo milk probiotic Dahi containing Lactobacillus acidophilus, Bifidobacterium bifidum and Lactococcus lactis reduces gastrointestinal cancer induced by dimethylhydrazine dihydrochloride in rats. Milchwissenschaft 63(2): 122-125.
13. Rajpal S, Kansal VK (2009) Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum attenuated diet induced 'olemia in rats. Milchwissenschaft 64(1): 21-25.
14. Rajpal S, Kansal VK (2009) Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum stimulates immune system in mice. Milchwissenschaft 64(2): 147-150.
15. Kaushal D, Kansal VK (2011) Probiotic Dahi containing Lactobacillus acidophilus and Bifidobacterium bifidum alleviates age-inflicted oxidative stress and improves expression of biomarkers of ageing in mice. Mol Biol Rep. doi: 10. 1007/s11033-011-0920-1.
16. AOAC (2005) In: Horowitz W (eds) Official methods of analysis, vol 45, 18th edn. Association of Official Analytical Chemists, Gaithersburg, 75-76.
17. Herias MV, Koninkx JFJG, Vos JG, Huis JHJ, van Dijk JE (2005) Probiotic effects of Lactobacillus casei on DSS-induced ulcerative colitis in mice. Int J Food Microbiol 103: 143-155.
18. Rosai J (2004) Gastrointestinal tract, large bowel. In: Rosai J (ed) Rosai and Ackerman's surgical pathology, 9th edn. Mosby, Philadelphia, pp 776-855.
19. Bradley PP, Priebat DA, Christensen RD, Rothstein G (1982) Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78: 206-209.
20. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin Phenol Reagent. J Biol Chem 193: 265-275.
21. Cummings JH, Macfarlane GT, Macfarlane S (2003) Intestinal bacteria and ulcerative colitis. Curr Issues Intest Microbiol 4: 9-20.
22. Kruis W (2004) Antibiotics and probiotics in inflammatory bowel disease. Aliment Pharmacol Ther 20(suppl. 4): 75-78.
23. Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics and prebiotics. Gastroenterology 126: 1620-1633.
24. Collins MP, Gibson GR (1999) Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 69: s1052-s1057.
25. Campieri M, Gionchetti P (1999) Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative. Gastroenterology 116: 1246-1260.
26. Madsen KL, Doyle JS, Jewell LD, Tavernini MM, Fedorak RN (1999) Lactobacillus species prevents colitis in interleukin 10 gene deficient mice. Gastroenterology 116: 1107-1114.
27. Bowen JM, Stringer AM, Gibson RJ, Yeoh AS, Hannam S, Keefe DM (2007) VSL#3 probiotic treatment reduces chemotherapy induced diarrhea and weight loss. Cancer Biol Ther 6: 1449-1454.
28. Chung YW, Choi JH, Oh TY, Eun CS, Han DS (2007) Lactobacillus casei prevents the development of dextran sulfate sodium-induced colitis in toll-like receptor 4 mutant mice. Clin Exp Immunol 151: 182-189.
29. Lee JH, Lee B, Lee HS, Bae EA, Lee H, Ahn YT, Lim KS, Huh CS, Kim DH (2009) Lactobacillus suntoryeus inhibits pro-inflammatory cytokine expression and TLR-4-linked NF-kappaB activation in experimental colitis. Int J Colorectal Dis 24(2): 231-237.
30. Hegazy SK, El-Bedewy MM (2010) Effect of probiotics on pro-inflammatory cytokines and NF-kappaB activation in ulcerative colitis. World J Gastroenterol 16(33): 4145-4151.
31. Shibolet O, Karmeli F, Eliakim R, Swennen E, Brigidi P, Gionchetti P, Campieri M, Morgenstern S, Rachmilewitz D (2002) Variable response to probiotics in two models of experimental colitis in rats. Inflamm Bowel Dis 8: 399-406.
32. Papadakis KA, Targan SR (2000) Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51: 289-298.
33. Bai AP, Ouyang Q (2006) Probiotics and inflammatory bowel diseases. Postgrad Med J 82: 376-382.
34. Furrie E, Macfarlane S, Kennedy A et al (2005) Synbiotic therapy (Bifidobacterium longum/Synergy1) initiates resolution of inflammation in patients with active ulcerative colitis: a randomised controlled pilot trial. Gut 54: 242-249.
35. MacDonald TT, Murch SH (1994) Aetiology and pathogenesis of chronic inflammatory bowel disease. Baillieres Clin Gastroenterol 8: 1-34.
36. Zheng P, Niu F, Liu W, Shi Y, Lu L (2005) Anti-inflammatory mechanism of oxymatrine in dextran sulfate sodium-induced colitis of rats. World J Gastroenterol 11(31): 4912-4915.
37. Bai A, Lu N, Guo Y, Fan X (2008) Tanshinone IIA ameliorates trinitrobenzene sulfonic acid (TNBS)-induced murine colitis. Dig Dis Sci 53: 421-428.
38. Barthet M, Dubucquoy L, Garcia S, Gasmi S, Descreumaux P, Colombel JF, Grimaud JC, Iovanna J, Dagorn JC (2003) Pancreatic changes in TNBS-induced colitis in mice. Gastroenterol Clin Biol 27: 895-900.
39. Madsen K, Cornish A, Soper P et al (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121: 580-591.